Skip to Main Content

Author Details

Carmen Rodriguez
Institut de Recherche en Cancerologie de Montpellier
1993
135
63
PMIDPaper TitleJournal TitlePublished Year
34503257A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors.Cancers (Basel)2021
34503257A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors.Cancers (Basel)2021
29522133Varicella Outbreak Surveillance in Schools in Sentinel Jurisdictions, 2012-2015.J Pediatric Infect Dis Soc2019
29522133Varicella Outbreak Surveillance in Schools in Sentinel Jurisdictions, 2012-2015.J Pediatric Infect Dis Soc2019
29092936Software for the Integration of Multiomics Experiments in Bioconductor.Cancer Res2017
28414308Complex regulation of LCoR signaling in breast cancer cells.Oncogene2017
29092936Software for the Integration of Multiomics Experiments in Bioconductor.Cancer Res2017
28414308Complex regulation of LCoR signaling in breast cancer cells.Oncogene2017
26930713Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.Oncotarget2016
26930713Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.Oncotarget2016
21435435Prognostic significance of TRIM24/TIF-1α gene expression in breast cancer.Am J Pathol2011
21435435Prognostic significance of TRIM24/TIF-1α gene expression in breast cancer.Am J Pathol2011
20051228CTCF is a DNA methylation-sensitive positive regulator of the INK/ARF locus.Biochem Biophys Res Commun2010
20051228CTCF is a DNA methylation-sensitive positive regulator of the INK/ARF locus.Biochem Biophys Res Commun2010
19156895Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype.Cancer2009
19406919Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: insights from simulations based on serum 25-hydroxyvitamin d.Am J Epidemiol2009
19396555Family history of various cancers and pancreatic cancer mortality in a large cohort.Cancer Causes Control2009
19067188Use of blood-pressure-lowering medication and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.Cancer Causes Control2009
19156895Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype.Cancer2009
19153072Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk.Hum Mol Genet2009
19505914Two independent prostate cancer risk-associated Loci at 11q13.Cancer Epidemiol Biomarkers Prev2009
19396555Family history of various cancers and pancreatic cancer mortality in a large cohort.Cancer Causes Control2009
19406919Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: insights from simulations based on serum 25-hydroxyvitamin d.Am J Epidemiol2009
19505914Two independent prostate cancer risk-associated Loci at 11q13.Cancer Epidemiol Biomarkers Prev2009
19153072Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk.Hum Mol Genet2009
19067188Use of blood-pressure-lowering medication and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.Cancer Causes Control2009
18196539TNF polymorphisms and prostate cancer risk.Prostate2008
19064578No association of single nucleotide polymorphisms in one-carbon metabolism genes with prostate cancer risk.Cancer Epidemiol Biomarkers Prev2008
17999989Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies.Carcinogenesis2008
18349283Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort.Cancer Epidemiol Biomarkers Prev2008
18622427Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol zeta.Oncogene2008
18202102SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer.Hum Mol Genet2008
18381473Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies.Cancer Epidemiol Biomarkers Prev2008
18196539TNF polymorphisms and prostate cancer risk.Prostate2008
18187388Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.Cancer Epidemiol Biomarkers Prev2008
18651569The role of body weight in the relationship between physical activity and endometrial cancer: results from a large cohort of US women.Int J Cancer2008
18500687Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort.Prostate2008
18322811A prospective study of waist circumference and body mass index in relation to colorectal cancer incidence.Cancer Causes Control2008
18752252Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.Int J Cancer2008
18398039Polymorphisms in angiogenesis-related genes and prostate cancer.Cancer Epidemiol Biomarkers Prev2008
18264096Multiple loci identified in a genome-wide association study of prostate cancer.Nat Genet2008
18752252Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.Int J Cancer2008
19064578No association of single nucleotide polymorphisms in one-carbon metabolism genes with prostate cancer risk.Cancer Epidemiol Biomarkers Prev2008
18500687Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort.Prostate2008
18622427Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol zeta.Oncogene2008
18651569The role of body weight in the relationship between physical activity and endometrial cancer: results from a large cohort of US women.Int J Cancer2008
18322811A prospective study of waist circumference and body mass index in relation to colorectal cancer incidence.Cancer Causes Control2008
18202102SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer.Hum Mol Genet2008
18264096Multiple loci identified in a genome-wide association study of prostate cancer.Nat Genet2008
18381473Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies.Cancer Epidemiol Biomarkers Prev2008
  • 1 - 50 of 270

Recommended Authors

Huntsman Cancer Institute, University of Utah
Career Start Year 2004
Number of shared co-authors 25
National Cancer Institute, National Institute of Health, 9 Medical Center Drive
Career Start Year 2002
Number of shared co-authors 10
Fred Hutchinson Cancer Center
Career Start Year 1998
Number of shared co-authors 3
Hollings Cancer Center, Medical University of South Carolina
Career Start Year 1998
Number of shared co-authors 18
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1998
Number of shared co-authors 16
University of Michigan School of Public Health ann arbor
Career Start Year 1995
Number of shared co-authors 21
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 32
Keck School of Medicine, University of Southern California
Career Start Year 1992
Number of shared co-authors 16
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 0
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Career Start Year 1991
Number of shared co-authors 26
National Cancer Institute.
Career Start Year 1990
Number of shared co-authors 24
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Career Start Year 1990
Number of shared co-authors 29
Fred Hutchinson Cancer Research Center
Career Start Year 1989
Number of shared co-authors 17
Laval University Cancer Research Center
Career Start Year 1989
Number of shared co-authors 2
Rollins School of Public Health, Emory University
Career Start Year 1988
Number of shared co-authors 23
University of Toronto Dalla Lana School of Public Health
Career Start Year 1988
Number of shared co-authors 23
University of California irvine
Career Start Year 1988
Number of shared co-authors 21
Laval University
Career Start Year 1986
Number of shared co-authors 2
German Cancer Research Center (DKFZ)
Career Start Year 1984
Number of shared co-authors 31
University of Hawaii Cancer Center
Career Start Year 1984
Number of shared co-authors 28
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1983
Number of shared co-authors 23
University of North Carolina at Chapel Hill
Career Start Year 1983
Number of shared co-authors 16
University of Cambridge
Career Start Year 1982
Number of shared co-authors 29
University of Southern California
Career Start Year 1981
Number of shared co-authors 25
Keck School of Medicine, University of Southern California
Career Start Year 1981
Number of shared co-authors 4
Fred Hutchinson Cancer Research Center
Career Start Year 1980
Number of shared co-authors 28
Mayo Clinic
Career Start Year 1979
Number of shared co-authors 19
National Cancer Institute
Career Start Year 1973
Number of shared co-authors 28
Vanderbilt University Medical Center
Career Start Year 1972
Number of shared co-authors 31
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Career Start Year 1964
Number of shared co-authors 17

Collaborators

Co-authored papers 89
Co-authored papers 86
Co-authored papers 22
The Kolling Institute, University of Sydney, and Royal North Shore Hospital
Co-authored papers 14
National Cancer Institute, National Institutes of Health
Co-authored papers 9
Harvard T. H. Chan School of Public Health
Co-authored papers 9
Harvard T.H. Chan School of Public Health
Co-authored papers 9
Co-authored papers 9
Albert Einstein College of Medicine
Co-authored papers 8
School of Public Health and Health Professions, University at Buffalo
Co-authored papers 8
Co-authored papers 7
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 5
Harvard T. H. Chan School of Public Health
Co-authored papers 5
National Cancer Institute
Co-authored papers 5
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Frederick National Laboratory for Cancer Research
Co-authored papers 4
Co-authored papers 4
Co-authored papers 3
Dana-Farber Cancer Institute
Co-authored papers 3
Memorial Sloan-Kettering Cancer Center
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
University of Southern California
Co-authored papers 3